Financials

News Discussions Technicals Seasonals

688221 fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

—

—

—

—

—

—

—

—

About

Frontier Biotechnologies, Inc. engages in the research, development, production, and sale of medicines. It offers hypercholesterolemia treatment, broadly neutralising antibody, and transdermal patch for musculoskeletal pain. The company was founded by Dong Xie, Chang Jin Wang and Rong Jian Lu on January 15, 2013 and is headquartered in Nanjing, China.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends

688221 has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company